David P Luci - Net Worth and Insider Trading

David P Luci Net Worth

The estimated net worth of David P Luci is at least $2 Million dollars as of 2024-05-13. David P Luci is the President and CEO, 10% Owner of Acurx Pharmaceuticals Inc and owns about 1,078,543 shares of Acurx Pharmaceuticals Inc (ACXP) stock worth over $2 Million. Details can be seen in David P Luci's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David P Luci has not made any transactions after 2022-07-27 and currently still holds the listed stock(s).

Transaction Summary of David P Luci

David P Luci Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David P Luci owns 4 companies in total, including Enveric Biosciences Inc (ENVB) , PLx Pharma Winddown Corp (PLXPQ) , and Abeona Therapeutics Inc (ABEO) among others .

Click here to see the complete history of David P Luci’s form 4 insider trades.

Insider Ownership Summary of David P Luci

Ticker	Comapny	Transaction Date	Type of Owner
ENVB	Enveric Biosciences Inc	2018-02-08	director
PLXPQ	PLx Pharma Winddown Corp	2014-03-12	director & 10 percent owner & President & CEO & Secretary
ABEO	Abeona Therapeutics Inc	2007-01-04	director
		2022-07-27	director & 10 percent owner & President and CEO

David P Luci Latest Holdings Summary

David P Luci currently owns a total of 1 stock. David P Luci owns 1,078,543 shares of Acurx Pharmaceuticals Inc (ACXP) as of July 27, 2022, with a value of $2 Million.

Latest Holdings of David P Luci

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ACXP	Acurx Pharmaceuticals Inc	2022-07-27	1,078,543	2.05	2,211,121

Holding Weightings of David P Luci

David P Luci Form 4 Trading Tracker

According to the SEC Form 4 filings, David P Luci has made a total of 2 transactions in Acurx Pharmaceuticals Inc (ACXP) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Acurx Pharmaceuticals Inc is the acquisition of 19,737 shares on July 27, 2022, which cost David P Luci around $75,001.

Insider Trading History of David P Luci

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David P Luci Trading Performance

GuruFocus tracks the stock performance after each of David P Luci's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David P Luci is -15.12%. GuruFocus also compares David P Luci's trading performance to market benchmark return within the same time period. The performance of stocks bought by David P Luci within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how David P Luci's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of David P Luci

Average Return

Average return per transaction

Outperforming Transactions

0 out of 2 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-8.21
Relative Return to S&P 500(%)	-7.81

David P Luci Ownership Network

Ownership Network List of David P Luci

No Data

Ownership Network Relation of David P Luci

David P Luci Owned Company Details

What does Enveric Biosciences Inc do?

Who are the key executives at Enveric Biosciences Inc?

David P Luci is the director of Enveric Biosciences Inc. Other key executives at Enveric Biosciences Inc include Chief Financial Officer Kevin Michael Coveney , Chief Financial Officer Robert Iv Dickey , and Chief Scientific Officer Peter J. Facchini .

Enveric Biosciences Inc (ENVB) Insider Trades Summary

Over the past 18 months, David P Luci made no insider transaction in Enveric Biosciences Inc (ENVB). Other recent insider transactions involving Enveric Biosciences Inc (ENVB) include a net purchase of 1,000 shares made by Frank Pasqualone ,

In summary, during the past 3 months, insiders sold 0 shares of Enveric Biosciences Inc (ENVB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Enveric Biosciences Inc (ENVB) were sold and 1,000 shares were bought by its insiders, resulting in a net purchase of 1,000 shares.

Enveric Biosciences Inc (ENVB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Enveric Biosciences Inc Insider Transactions

No Available Data

What does PLx Pharma Winddown Corp do?

Who are the key executives at PLx Pharma Winddown Corp?

David P Luci is the director & 10 percent owner & President & CEO & Secretary of PLx Pharma Winddown Corp. Other key executives at PLx Pharma Winddown Corp include director & Chief Executive Officer Natasha Giordano , Chief Financial Officer Rita M O'connor , and director & Executive Chairman Michael J Valentino .

PLx Pharma Winddown Corp (PLXPQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of PLx Pharma Winddown Corp (PLXPQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PLx Pharma Winddown Corp (PLXPQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PLx Pharma Winddown Corp (PLXPQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

PLx Pharma Winddown Corp Insider Transactions

No Available Data

What does Abeona Therapeutics Inc do?

Who are the key executives at Abeona Therapeutics Inc?

David P Luci is the director of Abeona Therapeutics Inc. Other key executives at Abeona Therapeutics Inc include SVP & General Counsel Brendan M. O'malley , director & Chief Executive Officer Vishwas Seshadri , and Chief Financial Officer Joseph Walter Vazzano .

Abeona Therapeutics Inc (ABEO) Insider Trades Summary

Over the past 18 months, David P Luci made no insider transaction in Abeona Therapeutics Inc (ABEO). Other recent insider transactions involving Abeona Therapeutics Inc (ABEO) include a net sale of 7,443 shares made by Michael Amoroso , a net purchase of 24,969 shares made by Brendan M. O'malley , and a net purchase of 50,000 shares made by Vishwas Seshadri .

In summary, during the past 3 months, insiders sold 0 shares of Abeona Therapeutics Inc (ABEO) in total and bought 31,758 shares, with a net purchase of 31,758 shares. During the past 18 months, 43,636 shares of Abeona Therapeutics Inc (ABEO) were sold and 93,627 shares were bought by its insiders, resulting in a net purchase of 49,991 shares.

Abeona Therapeutics Inc (ABEO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Abeona Therapeutics Inc Insider Transactions

No Available Data

What does Acurx Pharmaceuticals Inc do?

Who are the key executives at Acurx Pharmaceuticals Inc?

David P Luci is the director & 10 percent owner & President and CEO of Acurx Pharmaceuticals Inc. Other key executives at Acurx Pharmaceuticals Inc include director & 10 percent owner Robert J Deluccia , and Chief Financial Officer Robert G. Shawah .

Acurx Pharmaceuticals Inc (ACXP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Acurx Pharmaceuticals Inc (ACXP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acurx Pharmaceuticals Inc (ACXP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Acurx Pharmaceuticals Inc (ACXP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Acurx Pharmaceuticals Inc Insider Transactions

No Available Data

David P Luci Mailing Address

Above is the net worth, insider trading, and ownership report for David P Luci. Currently GuruFocus does not have mailing address information for David P Luci.

Discussions on David P Luci

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.